HUBEONE@EC2601A(17424.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
HUBEONE@EC2601A
17424.HK
News
View More

In "Major Banks," CICC lists potential "blue-chip" companies for the Hang Seng Index's semi-annual adjustment (table)

CICC released a report predicting potential companies for inclusion in the Hang Seng Index's semi-annual adjustment, including Zijin Mining International, Beigene, YUM China, etc., along with the possible weight and capital inflow situation. At the same time, companies such as Standard Chartered and Swire Properties may be included in the Hang Seng Index as replacements due to the delisting of Hang Seng Bank

AASTOCKS·
US
BGNE
0.00%
SH
688235
-1.11%
HK
06160
-0.38%
AASTOCKS·
US
BGNE
0.00%
SH
688235
-1.11%
HK
06160
-0.38%

Beigene's "BeYueDa" completes its first sale in Beijing

China National Pharmaceutical Group announced that as the preferred distributor for BeiGene's new product "BaYueDa" in Beijing, it successfully completed the first order delivery for BeiGene yesterday (14th). The medication arrived at China National Pharmaceutical Group's logistics in the afternoon of the same day, and with the cooperation and coordination of relevant departments such as the procurement center, Beijing direct sales center, and China National Pharmaceutical Group logistics, it was delivered to the designated DTP pharmacy within 3 hours after arrival

AASTOCKS·
SH
688235
-1.11%
US
BGNE
0.00%
HK
06160
-0.38%
AASTOCKS·
SH
688235
-1.11%
US
BGNE
0.00%
HK
06160
-0.38%

Hong Kong Exchanges and Clearing (HKEX) launches new stock options category

Hong Kong Exchanges and Clearing (HKEX) announced that it will launch six new categories of stock options on January 19, 2026, to expand the stock options market and provide more choices for investors. Last year, the average daily trading volume of the derivatives market at HKEX reached a new high, and the average daily trading volume of stock options also increased significantly. The newly launched options include stocks from companies such as Zijin Mining, Wuxi AppTec, and Beigene, with contract trading units and expiration months already announced

港交所·
SH
603259
+2.42%
HK
02359
+1.76%
US
HKXCY
+0.63%
港交所·
SH
603259
+2.42%
HK
02359
+1.76%
US
HKXCY
+0.63%

Hong Kong stock movement: The innovative drug industry explodes, REMEGEN rises 10.04%

REMEGEN rose 10.04%; Innovent Biologics rose 4.20%, with a transaction volume reaching HKD 1.214 billion; CanSino Biologics rose 5.48%, with a transaction volume reaching HKD 1.058 billion; BeiGene rose 1.92%, with a transaction volume reaching HKD 844 million; Kelun-Biotech rose 4.31%, with a market value reaching HKD 107.3 billion

HK Stock Movers Tracker·
HK
09995
-2.70%
HK
01801
-2.42%
HK
09926
-2.30%
HK Stock Movers Tracker·
HK
09995
-2.70%
HK
01801
-2.42%
HK
09926
-2.30%

BeOne Medicines Granted U.S. FDA Fast Track Designation For BGB-B2033

Dec 18 (Reuters) - BeOne Medicines AG (688235.SS) :* BEONE MEDICINES GRANTED U.S. FDA FAST TRACK DESIGNATION FOR BGB-B2033 AS TREATMENT FOR HEPATOCELLULAR CARCINOMA Source text: Further company coverage: (688235.SS)

Reuters·
SH
688235
-1.11%
US
BGNE
0.00%
HK
06160
-0.38%
Reuters·
SH
688235
-1.11%
US
BGNE
0.00%
HK
06160
-0.38%
Posts
View More

$Beigene(ONC.US)$Zai Lab(ZLAB.US)Trump administration plans to impose strict controls on Chinese pharmaceuticals

mp.weixin.qq.com/s/gihUP-...

The annual portfolio return for 2024 is around 8%, far below expectations. This is mainly due to significant negative contributions from $PDD(PDD.US) and $Li Auto(LI.US).

Tonight, I will open a new U.S...

  • 0
© 2026 Longbridge｜Disclaimer